• VERTEX PHARMACEUTICALS INC Cash Flow

  • View:
    Annual Data | Quarterly Data
    Period Ending FY2007 FY2006 FY2005 FY2004 FY2003
    Net Income/Starting Line -391.28 M -206.89 M -203.42 M -166.25 M -196.77 M
    Operating Activities
    Depreciation, Depletion & Amortization 27.46 M 25.87 M 27.29 M 29.64 M 23.44 M
    Depreciation & Depletion 27.30 M 25.40 M 26.31 M 28.35 M 23.44 M
    Amortization of Intangible Assets 159,000.00 468,000.00 982,000.00 1.29 M 0.00
    Deferred Income Taxes and Investment Tax credity 101.22 M 116.30 M 851,000.00 18.34 M 51.77 M
    Deferred Income Taxes 101.22 M 116.30 M 851,000.00 18.34 M 51.77 M
    Income Tax Credit
    Other Cash Flow 64.04 M 35.49 M 56.15 M 7.19 M 7.10 M
    Funds from Operations -299.78 M -145.53 M -119.98 M -129.42 M -236.57 M
    Extraordinary Items & Discontinued Operations 0.00 0.00 0.00 0.00 0.00
    Funds from/for Other Operating Activities 47.30 M 123.05 M -52.07 M -12.74 M 68.94 M
    Incline (Decline) in Receivables 31.60 M -42.33 M -8.70 M -4.57 M 1.57 M
    Incline (Decline) in Inventories 0.00 0.00 0.00 0.00 0.00
    Incline (Decline) in Accounts Payable 17.38 M 9.16 M -450,000.00 -5.65 M -2.15 M
    Incline (Decline) in Income Taxes Payable 0.00 0.00 0.00 0.00 0.00
    Incline (Decline) in Other Accruals 22.56 M 38.89 M -8.33 M -9.91 M 65.48 M
    Incline (Decline) in Other Assets or Liabilties -24.24 M 117.33 M -34.59 M 7.39 M 4.04 M
    Net Cash Flow/Operating Activities -252.48 M -22.48 M -172.05 M -142.16 M -167.62 M
    Capital Expenditures (Additions to Fixed Assets)
    Additions to Other Assets 0.00 0.00 59,000.00 136,000.00 0.00
    Net Assets from Acquisitions 0.00 0.00 0.00 0.00 0.00
    Incline (Decline) in Inventories 317.47 M 508.08 M 236.49 M 148.51 M 555.84 M
    Decrease in Investments 755.62 M 320.63 M 243.41 M 292.35 M 594.00 M
    Disposal of Fixed Assets 0.00 0.00 0.00 0.00 0.00
    Other Uses - Investing 569,000.00 -11.40 M -8.36 M 23.79 M -98.78 M
    Other Sources - Investing 0.00 11.40 M 8.36 M 0.00 98.78 M
    Net Cash Flow - Investing -405.17 M 208.47 M 1.73 M -107.43 M -119.58 M
    Proceeds from Stock Options 31.96 M 0.00 0.00 0.00 0.00
    Other Proceeds from Sale/Issues of Stock 0.00 366.04 M 197.46 M 8.74 M 11.96 M
    Com/Pfd Purchase, Retired, Converted, Redeemed 0.00 0.00 0.00 0.00 0.00
    Financing Activities
    Long Term Borrowings 0.00 0.00 0.00 0.00 27.46 M
    Incline or Decline in Short Term Borrowings -42.10 M 0.00 0.00 0.00 0.00
    Reduction in Long Term Debt 0.00 0.00 0.00 12.56 M 1.95 M
    Cash Dividends Paid Total 0.00 0.00 0.00 0.00 0.00
    Common Dividends (Cash) 0.00 0.00 0.00 0.00 0.00
    Preferred Dividends (Cash) 0.00 0.00 0.00 0.00 0.00
    Other Sources - Financing 0.00 0.00 0.00 0.00 0.00
    Other Uses - Financing -53,000.00 -170,000.00 0.00 -4.80 M 0.00
    Net Cash Flow - Financing -10.19 M 365.86 M 197.46 M -8.63 M 37.47 M
    Effect of Exchange rate on Cash -8,000.00 207,000.00 -631,000.00 205,000.00 631,000.00
    Changes in Cash and/or Liquid Items